SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-12-005852
Filing Date
2012-11-14
Accepted
2012-11-14 14:31:58
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT slxcf_10q.htm 10-Q 667994
2 CERTIFICATION slxcf_ex311.htm EX-31.1 15602
3 CERTIFICATION slxcf_ex312.htm EX-31.2 16061
4 CERTIFICATION slxcf_ex321.htm EX-32.1 6643
5 CERTIFICATION slxcf_ex322.htm EX-32.2 7420
  Complete submission text file 0001354488-12-005852.txt   3595888

Data Files

Seq Description Document Type Size
6 slxcf-20120930.xml EX-101.INS 417970
7 slxcf-20120930.xsd EX-101.SCH 34247
8 slxcf-20120930_cal.xml EX-101.CAL 53039
9 slxcf-20120930_def.xml EX-101.DEF 59390
10 slxcf-20120930_lab.xml EX-101.LAB 212679
11 slxcf-20120930_pre.xml EX-101.PRE 166741
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
STELLAR PHARMACEUTICALS INC (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31198 | Film No.: 121203384
SIC: 2834 Pharmaceutical Preparations